Belite Bio, Inc. (BLTE)
149.13
-0.78
(-0.52%)
USD |
NASDAQ |
Dec 09, 16:00
148.76
-0.37
(-0.25%)
After-Hours: 20:00
Belite Bio Shareholders Equity (Quarterly): 274.08M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ocugen, Inc. | 3.533M |
| Ionis Pharmaceuticals, Inc. | 617.97M |
| INVO Fertility, Inc. | 5.849M |
| IDEAYA Biosciences, Inc. | 1.092B |
| Janux Therapeutics, Inc. | 976.56M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 282.39M |
| Total Liabilities (Quarterly) | 8.311M |
| Debt to Equity Ratio | 0.0019 |
| Current Ratio | 34.37 |
| Net Debt Paydown Yield | -0.00% |